High-Resolution CT and CT Pulmonary Angiography Ranked Most Influential Advances in Cardiopulmonary Imaging in the Past 25 Years

Newswise — Advances in computed tomography (CT) providing high-resolution images of the lungs and a new approach to diagnosis of pulmonary embolism (PE) are "the most influential" changes in cardiopulmonary imaging over the past 25 years, according to a panel of experts surveyed in the February Journal of Thoracic Imaging (http://www.thoracicimaging.com) official journal of the Society of Thoracic Radiology and the Japanese and Korean Societies of Thoracic Radiology. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

To mark the 25th anniversary of the Journal of Thoracic Imaging, the editors asked 25 international leaders in cardiopulmonary imaging, "What is the most influential article or advance in our specialty in the past 25 years?" "High-resolution CT and CT pulmonary angiography were the leading specialty-specific responses," says Phillip M. Boiselle, M.D., Editor-in-Chief of JTI.

Once-Revolutionary Techniques Are Now Part of Routine Cardiopulmonary Imaging High-resolution CT—a technique providing much more highly detailed images of the lungs than conventional CT—was cited as the most important advance in pulmonary imaging. "[H]igh-resolution chest CT...has permitted a much greater understanding of interstitial lung disease," says contributor Theresa McLoud, M.D. "It has increased the accuracy of diagnosis, and the ability of the radiologist to understand the anatomic distribution of disease at the lobular level, to provide a quantitative analysis of the severity of disease and to assess response to treatment."

The experts rated CT pulmonary angiography—which has greatly enhanced the challenging diagnosis of PE—as the most influential new advance in cardiopulmonary imaging. A seminal 1992 study by Martine Remy-Jardin, M.D., Ph.D., comparing spiral CT angiography to conventional angiography for diagnosis of PE was cited as the single most influential article of the past 25 years. "A truly disruptive technique in radiology completely changes the way a disease is diagnosed," comments Lawrence R. Goodman, M.D. "This paper totally changed the diagnostic approach to PE and in addition has provided new clinical insights into a perplexing disease."

When the first issue of JTI appeared in 1985, high-resolution CT was a revolutionary new approach on the cutting edge of radiology and CT pulmonary angiography was hardly imaginable, Dr. Boiselle points out. These same technologies now comprise the mainstay of thoracic imaging. Other advances cited by the experts include multidetector-row CT technology, CT coronary angiography, and cardiac MRI.

The article, the first of a special "25 on 25" series, is also freely available online at the JTI website, www.thoracicimaging.com. The journal website also features a "quick poll" in which readers can give their opinions on the most important advances, as well as access to other special 25th anniversary features. The "25 on 25" series will continue throughout 2010, as the experts share their views on which advances failed to live up to expectations, the greatest opportunities and challenges facing cardiopulmonary imaging, and what the specialty will look like in 2035.

About the Journal of Thoracic ImagingThe Journal of Thoracic Imaging (http://www.thoracicimaging.com), the official journal of the Society of Thoracic Radiology and the Japanese and Korean Societies of Thoracic Radiology, provides authoritative information on all aspects of the use of imaging techniques in the diagnosis of chest disease. Original articles and analytical reviews published in this timely journal provide the very latest thinking of leading experts concerning the use of conventional chest radiography, tomography, computed tomography, digitized radiography, ultrasound medicine, magnetic resonance imaging, and all other promising techniques of thoracic radiology.

Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.

LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.

About Wolters Kluwer HealthWolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2009 annual revenues of €3.4 billion ($4.8 billion), employs approximately 18,200 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

###